Showing results (1541-1550 of 1,759) with videos related to

Sort By:
Pageof 176
Journal of Medicinal Chemistry|March 15, 2021
Discovery of Selective Pituitary Adenylate Cyclase 1 Receptor (PAC1R) Antagonist Peptides Potent in a Maxadilan/PACAP38-Induced Increase in Blood Flow Pharmacodynamic ModelEssa Hu, Fang-Tsao Hong, Jennifer Aral, et al.
Thyroid Research|March 6, 2022
Use of thyroid hormones in hypothyroid and euthyroid patients: a THESIS* survey of Belgian specialists *THESIS: treatment of hypothyroidism in Europe by specialists: an international surveyMaria-Cristina Burlacu, Roberto Attanasio, Laszlo Hegedüs, et al.
Radiology|November 28, 2008
Subtraction MR images in a multiple sclerosis multicenter clinical trial settingBastiaan Moraal, Dominik S Meier, Peter A Poppe, et al.
Archives of Neurology|September 12, 2007
Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year resultsFrederik Barkhof, Chris H Polman, Ernst-Wilhelm Radue, et al.
Stroke|December 8, 2016
Early Trajectory of Stroke Severity Predicts Long-Term Functional Outcomes in Ischemic Stroke Subjects: Results From the ESCAPE Trial (Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT to Recanalization Times)Tolulope T Sajobi, Bijoy K Menon, Meng Wang, et al.
Journal of the American Heart Association|April 19, 2024
Longitudinal NT-proBNP: Associations With Echocardiographic Changes and Outcomes in Heart FailureKanako Teramoto, Wan Ting Tay, Jasper Tromp, et al.
Maturitas|April 24, 2024
EMAS position statement: Thyroid disease and menopauseGesthimani Mintziori, Stavroula Veneti, Kris Poppe, et al.
AJNR. American Journal of Neuroradiology|June 25, 2021
Strength of Association between Infarct Volume and Clinical Outcome Depends on the Magnitude of Infarct Size: Results from the ESCAPE-NA1 TrialJ M Ospel, M D Hill, B K Menon, et al.
Haematologica|September 26, 2008
EVI1 overexpression in t(3;17) positive myeloid malignancies results from juxtaposition of EVI1 to the MSI2 locus at 17q22An De Weer, Frank Speleman, Barbara Cauwelier, et al.
BMC Cancer|November 19, 2015
BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancerF Z Francies, T Wainstein, K De Leeneer, et al.
Pageof 176